BDBM271393 4- {[(1R,2R,5R,10S,13R,14R, 17S,19R)-5-(2-{[(4- chlorophenyl)methyl][2- (dimethylamino)ethyl] amino}ethyl)-1,2,14,18,18- pentamethyl-7-oxo-8- (propan-2- yl)pentacyclo[11.8.0.0{circumflex over ()} {2,10}.0{circumflex over ()}{5,9}.0{circumflex over ()}{14,19}] henicos-8-en-17-yl]oxy}- 2,2-dimethyl-4- oxobutanoic acid::US10064873, Example 10
SMILES [H][C@]12CC[C@]3([H])[C@@]4(C)CC[C@H](OC(=O)CC(C)(C)C(O)=O)C(C)(C)[C@]4([H])CC[C@@]3(C)[C@]1(C)CC[C@@]1(CCN(CCN(C)C)Cc3ccc(Cl)cc3)CC(=O)C(C(C)C)=C21
InChI Key InChIKey=TYWMSUNKKDGGDV-BNVVCDBTSA-N
Data 2 EC50
Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB
Found 2 hits for monomerid = 271393
Affinity DataEC50: 2.40nMAssay Description:Antiviral HIV activity and compound-induced cytotoxicity were measured in parallel by means of a propidium iodide based procedure in the human T-cell...More data for this Ligand-Target Pair
TargetEnvelope glycoprotein gp160(Human immunodeficiency virus type 1 (isolate BRU/L...)
Glaxosmithkline
US Patent
Glaxosmithkline
US Patent
Affinity DataEC50: 2.30nMAssay Description:Antiviral HIV activity and compound-induced cytotoxicity were measured in parallel by means of a propidium iodide based procedure in the human T-cell...More data for this Ligand-Target Pair